Search Results 611-620 of 19710 for Receptor
A Study of Cell, Serum, and Bone Marrow Bank for Patients receiving Chimeric Antigen Receptor T Cell Therapy for the Treatment of Cancer. Rochester, Minn ...
They found that the APOE4 protein produced by the gene, can bind more aggressively to insulin receptors on the surfaces of neurons than its normal counterpart, ...
... receptor positive, estrogen receptor-positive, human epidermal growth receptor-2 negative metastatic breast cancer after progression on previous endocrine ...
About this study. This randomized pilot clinical trial studies melanoma antigen recognized by T-cells 1 (MART-1) antigen with or without toll-like receptor ...
Mayo Clinic Radio: Chimeric antigen receptor T-cell therapy / coronary artery disease / kids and infections · Housecall: Is your nest suddenly empty? Related ...
OCA is a modified bile acid that is a farnesoid X receptor (FXR) agonist. Conducted at Mayo Clinic's campuses in Arizona and Minnesota, this trial looks at ...
Chimeric antigen receptor (CAR)-T cell therapy has become a safe and effective treatment option for a growing number of indications. While initially posed ...
Their initial work suggested a link between the BRD9 protein and a receptor that controls the action of a type of steroid called glucocorticoids. "For this ...
About this study. The treatment for postmenopausal women diagnosed with hormone receptor positive (HR+) metastatic breast cancer (mBr) includes endocrine ...
... receptor-expressing breast cancer. Project 4: P95HER2, Antitumor Immunity and the Efficacy of HER2-Directed Antibody Drug Conjugates is studying p95HER2 for ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.